PAVmed
NASDAQ: PAVMNew York, US · Founded 2014 · Delaware corporation
Find your way into PAVmed
600 people in our graph share verified history with the PAVmed team — schools, employers, funds. One of them is your warm intro.
Lyle McCullochunlockedknows Richard Fitzgerald · together at PwC (overlapped)
×5knows the team · via PwC
×2knows the team · via Bucknell University
knows the team · via PECO, an Exelon Company
knows the team · via Pavilion Medical Innovations LLC
×2knows the team · via Rochester Institute of Technology
PAVmed is a medical technology company that develops and commercializes products across medical devices, diagnostics, and digital health through its subsidiaries. It serves healthcare systems, clinicians, and patients, with subsidiaries including Lucid Diagnostics (esophageal precancer and cancer detection) and Veris Health (remote patient monitoring for cancer care).
Founders & leadership
PAVmed was founded in 2014 by Michael J. Glennon, Lishan Aklog, Joshua R. Lamstein, and Brian Justo DeGuzman.
MJ
Michael J. GlennoninCo-founder · Board Director, Vice ChairmanMichael Glennon is Director at PAVmed, a medical technology company that develops diagnostic and monitoring products through subsidiaries including Lucid Diagnostics and Veris Health. He has prior experience in medical device business development.
LA
JR
Joshua R. LamsteinCo-founder
BJ
Brian Justo DeGuzmaninChief Technology Officer, Chief Compliance Officer & Co-FounderChief Technology Officer & Chief Compliance Officer at Lucid Diagnostics
DM
MA
SO
Shaun O'NeilinExecutive Vice President & Chief Operating OfficerShaun O'Neil is Executive Officer of PAVmed, a medical technology company that develops and commercializes medical devices, diagnostics, and digital health products through subsidiaries including Lucid Diagnostics, which focuses on esophageal precancer and cancer detection.
RF
Richard FitzgeraldinChief Financial Officer2015–2017Richard Fitzgerald is Executive Officer at PAVmed, a medical technology company with subsidiaries in diagnostics and digital health. He brings over three decades of finance and operational leadership in life sciences, including prior roles as CFO at Immunome and Sesen Bio, and earlier as CFO of PAVmed during its 2016 IPO, along with senior financial positions at Exelon Corporation and PricewaterhouseCoopers; he holds a B.S. in Business Administration and Accounting from Bucknell University.
SM
Shaun M. O'NeilinExecutive Vice President & Chief Operating OfficerShaun M. O'Neil serves as Executive Vice President and Chief Operating Officer at PAVmed, a medical technology company that develops and commercializes medical devices, diagnostics, and digital health products through subsidiaries including Lucid Diagnostics and Veris Health.
VT
Victoria T. LeeinEVP and Chief Medical Officer
Board
DJ
Debra J. WhiteBoard director
RM
Ronald M. SparksBoard director
Reported raises · per SEC filings
Form D private placements$69.1M disclosed across 9 rounds · 2014–2026
▶$30MraisedFeb 2026 · 14 investors · Other Health CareRule 506(b)
▶$30MraisedFeb 2026 · 14 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Debra J. WhiteDirector
- Lishan AklogExecutive Officer, Director
- Michael A. GordonExecutive Officer
- Ronald M. SparksDirector
- Shaun O'NeilExecutive Officer
- Sundeep AgrawalDirector
- Michael J. GlennonDirector
- Timothy E. BaxterDirector
- Dennis M. McGrathExecutive Officer
- Offering amount
- $60M
- Amount sold
- $30M
- First sale
- Feb 2026
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$2.7MraisedFeb 2025 · 1 investors · Other Health CareRule 506(b)
▶$2.7MraisedFeb 2025 · 1 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Michael J. GlennonDirector
- Dennis M. McGrathExecutive Officer
- Debra J. WhiteDirector
- Michael A. GordonExecutive Officer
- Ronald M. SparksDirector
- Shaun O'NeilExecutive Officer
- Sundeep AgrawalDirector
- Timothy E. BaxterDirector
- Lishan AklogExecutive Officer, Director
- Offering amount
- $2.7M
- Amount sold
- $2.7M
- First sale
- Jan 2025
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$7.8MraisedAug 2020 · 1 investors · Other Health CareRule 506(b)
▶$7.8MraisedAug 2020 · 1 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Dennis M. McGrathExecutive Officer
- Michael GlennonDirector
- Lishan AklogExecutive Officer, Director
- David S. Battleman, M.D.Director
- James L CoxDirector
- Richard YazbeckExecutive Officer
- Ronald M. SparksDirector
- David Scott Weild, IVDirector
- Shaun O'NeilExecutive Officer
- Offering amount
- $7.8M
- Amount sold
- $7.8M
- First sale
- Aug 2020
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$4.1MraisedMay 2020 · 1 investors · Other Health CareRule 506(b)
▶$4.1MraisedMay 2020 · 1 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Lishan AklogExecutive Officer, Director
- David Scott Weild, IVDirector
- Michael GlennonDirector
- Dennis M. McGrathExecutive Officer
- Ronald M. SparksDirector
- James L CoxDirector
- Richard YazbeckExecutive Officer
- David S. Battleman, M.D.Director
- Shaun O'NeilExecutive Officer
- Offering amount
- $4.1M
- Amount sold
- $4.1M
- Finders' fees
- $120.3K
- Placement agents
- Maxim Group LLC
- First sale
- Apr 2020
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$14MraisedNov 2019 · 2 investors · Other Health CareRule 506(b)
▶$14MraisedNov 2019 · 2 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Lishan AklogExecutive Officer, Director
- Michael GlennonDirector
- James L. CoxDirector
- Ronald M. SparksDirector
- David Scott Weild, IVDirector
- David S. Battleman, M.D.Director
- Dennis M. McGrathExecutive Officer
- Shaun O'NeilExecutive Officer
- Richard YazbeckExecutive Officer
- Offering amount
- $14M
- Amount sold
- $14M
- Finders' fees
- $819K
- Placement agents
- Maxim Group LLC
- First sale
- Nov 2019
- Incorporated
- Corporation, Delaware, 2014
- Federal exemptions
- 06b
▶$7.8MraisedJan 2019 · 1 investors · Other Health CareRule 506(b)
▶$7.8MraisedJan 2019 · 1 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Dennis M. McGrathExecutive Officer
- David S. Battleman, M.D.Director
- Michael GlennonDirector
- James L. Cox, M.D.Director
- Lishan Aklog, M.D.Executive Officer, Director
- Ronald M. SparksDirector
- David Scott Weild, IVDirector
- Brian J. DeGuzman, M.D.Executive Officer
- Offering amount
- $7.8M
- Amount sold
- $7.8M
- Finders' fees
- $455K
- Placement agents
- Maxim Group LLC
- First sale
- Dec 2018
- Incorporated
- Corporation, Delaware, 2014
- Federal exemptions
- 06b
▶$500KraisedAug 2017 · 6 investors · Other Health CareRule 506(b)
▶$500KraisedAug 2017 · 6 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- David Scott Weild, IVDirector
- Ronald M. SparksDirector
- Ira Scott GreenspanDirector
- Lishan AklogExecutive Officer, Director
- James L. CoxDirector
- David S. Battleman, M.D.Director
- Dennis M. McGrathExecutive Officer
- Joshua R. LamsteinDirector
- Michael GlennonDirector
- Offering amount
- $500K
- Amount sold
- $500K
- First sale
- Aug 2017
- Incorporated
- Corporation, Delaware, 2014
- Federal exemptions
- 06b
▶$1.5MraisedFeb 2017 · 13 investors · Other Health CareRule 506(b)
▶$1.5MraisedFeb 2017 · 13 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Ronald M. SparksDirector
- Joshua R. LamsteinDirector
- Richard FitzgeraldExecutive Officer
- James L. CoxDirector
- Lishan AklogExecutive Officer, Director
- David Weild, IVDirector
- Michael GlennonDirector
- Ira Scott GrenspanDirector
- Offering amount
- $3M
- Amount sold
- $1.5M
- Sales commissions
- $105.6K
- Placement agents
- Xzerta Trading LLC d/b/a HCFP/Capital Markets
- First sale
- Jan 2017
- Incorporated
- Corporation, Delaware, 2014
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 8
by search overlap
Robinhood25 shared keywordsRobinhood is a financial trading platform that enables users to manage portfolios across stocks, ETFs, cryptocurrencies, options, futures, and prediction markets. The platform serves retail investors with low barriers to entry, offering portfolio management services and market insights.
Seeking Alpha24 shared keywordsSeeking Alpha is a financial research platform offering stock analysis, market news, investment ideas, and quantitative ratings across asset classes, drawing on a large community of contributing analysts. It serves individual and professional investors seeking research and data-driven insight on stocks and markets.
StockTwits20 shared keywordsStocktwits operates an online community platform where investors and traders share ideas, analysis, and trade discussions organized around stock tickers. The page presented is its community guidelines rather than a product description.
Perplexity20 shared keywordsAn AI-powered answer engine providing accurate, trusted, and real-time answers to questions.
Simply Wall St19 shared keywordsSimply Wall St is an investment platform that provides financial data visualization and analysis tools for individual investors. The platform serves long-term investors globally by simplifying complex market information into visual and narrative formats to make stock investing more accessible.
TipRanks19 shared keywordsFinancial analysis and stock research platform.
Public18 shared keywordsPublic is a trading platform that allows users to buy and sell cryptocurrencies including Bitcoin, Ethereum, and memecoins through accounts managed by Zero Hash LLC, a New York State-licensed virtual currency business.
TradingView18 shared keywordsTradingView is a charting platform and social network used by over 100 million traders and investors worldwide to analyze and trade across global financial markets. The platform provides tools for technical analysis, market data, and community collaboration for retail and institutional traders.
Companies competing with PAVmed for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does PAVmed do?
- PAVmed is a medical technology company that develops and commercializes products across medical devices, diagnostics, and digital health through its subsidiaries. It serves healthcare systems, clinicians, and patients, with subsidiaries including Lucid Diagnostics (esophageal precancer and cancer detection) and Veris Health (remote patient monitoring for cancer care).
- Who founded PAVmed?
- PAVmed was founded by Michael J. Glennon, Lishan Aklog, Joshua R. Lamstein, Brian Justo DeGuzman in 2014.
- How much funding has PAVmed raised?
- PAVmed has disclosed $69.1M raised across 9 rounds.
- Where is PAVmed headquartered?
- PAVmed is headquartered in New York, US.